Navigation Links
CSHL scientists correlate enzyme expression levels with chemotherapy drug response
Date:7/18/2008

Why do cancer patients develop resistance to chemotherapy drugs, sometimes abruptly, after a period in which the drugs seem to be working well to reduce tumors or hold them in check? Although largely a mystery to scientists, the result when this occurs is all too familiar: patients relapse and in many cases die when their cancers become resistant.

A team of researchers at Cold Spring Harbor Laboratory (CSHL), seeking to understand the genetic underpinnings of cancer therapy response, have identified what they regard a "significant contributor to resistance." Using a novel screening technique involving "pools" of gene-regulating short RNA molecules, they were able to determine how resistance to a drug called doxorubicin arises in lymphomas occurring in a particular strain of mice.

Toward a "global view" of factors influencing therapy response

"The method we developed is notable," said CSHL Professor Scott W. Lowe, Ph.D., a leader of the research team, "because it gives us a view of how resistance works at the level of individual molecules in living animals, and also because it can be easily extended to other chemotherapy drugs and tumor systems to give a potentially global view of factors that mediate response to cancer therapy."

Many genetic factors are already known to influence the effectiveness of anti-cancer drugs. Such factors manifest themselves in a variety of ways, some of them remarkable. One known gene change, for instance, results in increased expression of pump-like mechanisms that remove chemotherapeutic toxins from cancer cells; another causes changes in cellular structure that prevent drug molecules from "docking" with their targets.

The research by the CSHL team, which included Professors W. Richard McCombie, Ph.D., and Gregory J. Hannon, Ph.D., in addition to Dr. Lowe, demonstrated the mechanism of one form of resistance in cell culture and living mice. These results were reported in Proce
'/>"/>

Contact: Jim Bono
bono@cshl.edu
516-367-8455
Cold Spring Harbor Laboratory
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... (PRWEB) September 02, 2014 The global ... USD 8,918.8 million by 2020, growing at an estimated ... a new study by Grand View Research, Inc. Peripheral ... plague modification devices are used for treating peripheral arterial ... of atherosclerotic plaques in arteries. These devices are used ...
(Date:9/2/2014)... 02, 2014 Researchers in New Delhi, India ... mesothelioma after being exposed to asbestos-contaminated work clothes for just ... details of the report in a new article. Click ... ESI Model Hospital say their patient was diagnosed with ... investigation found that she had come in contact with her ...
(Date:9/2/2014)... 02, 2014 MyRounding, the leader in ... been selected from a group of over 100 applicants ... PrIME Digital Health Challenge. The competition will pin Colorado’s ... Sept. 9th at the CSU Denver Atrium from 1 ... based in Denver, Colo. The cloud-based, SaaS (Software as ...
(Date:9/2/2014)... NY (PRWEB) September 02, 2014 Eric ... Color Me , a revolutionary makeup application device. ... puts clinically proven innovation in the palm of women’s ... , The secret to Color Me’s success lies in ... runs at a rate of 15,000 pulses per minute, ...
(Date:9/2/2014)... Headaches, both chronic and acute ruin lives. They ... and friends, sleeping and just coping well with daily activities. ... disability worldwide. The medications prescribed for these conditions frequently ... these cases of headache and back pain are of a ... not detect and fix the cause. , When a ...
Breaking Medicine News(10 mins):Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 3Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 4Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 5Health News:New Report Illustrates That Even Brief Asbestos Exposure Can Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:MyRounding Selected for Digital Health Venture Showcase Finals Top Three Startups Awarded $50,000 2Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 2Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 3Health News:Physical Therapists in Houston Learn Pain Relief Techniques 2
... better handled following discovery of a novel chemical compound ... the potential to be the basis of new therapies ... neurobiologists. ,Because exposure to people, places and objects ... memory-based cravings, many former drug users often relapse into ...
... a new method of Cryopreservation of ovaries for few years ... would be very useful for women with cancer, because during ... infertile is very high. This method involves removing the ovaries ... is finished the ovaries can be implanted back into them ...
... research letter published in the latest edition of The Lancet, ... male prisoners of prisons in UK is much higher than ... country, bringing to notice the existing conditions of the prisons ... in England and Wales, one of the highest proportions in ...
... has always remained a problem for parents because of the ... susceptibility to get easily influenced by peers // . A ... enjoy popularity are more likely to smoke than less popular ... in 16 Southern California middle schools. Over 1,486 students in ...
... has shown that marital problems affect men and women equally, ... the wife more than the husband. Furthermore, spouses in bad ... ,This finding could mean that couples face a greater ... that in addition to the carryover of work stress into ...
... cancer cases has reached about 1.2 million worldwide and Statistics ... in urban India and has overtaken cancer of the cervix ... metros according to a study conducted on women and cancer ... delayed motherhood are some factors that can lead to a ...
Cached Medicine News:Health News:Neurobiology Provides Answers To Block Memory-Related Drug Cravings 2Health News:Cryopreservation of Ovaries for Cancer patients undergoing treatment 2Health News:Suicide Rate Amongst Male Prisoners Of UK Is Quite High 2Health News:Popularity Among Peers Increases Susceptibility To Smoking Habit Among School Children 2
(Date:9/2/2014)... SAN ANTONIO , Sept. 2, 2014 /PRNewswire/ ... private medical technology company focused on innovating lifesaving ... announced the appointment of Dr. Gabriele Niederauer ... President and CEO. Following the recent closure of ... CE Mark for the Surfacer™ Inside-Out Access Catheter ...
(Date:9/2/2014)... , Sept. 2, 2014   Veracyte, Inc. (Nasdaq: ... Anderson , president and chief executive officer, will present in ... Healthcare Unplugged Conference 2014 on Monday, September 8, 2014 at ... The live audio webcast and subsequent replay may ... Please connect to the website at least 15 minutes prior ...
(Date:9/2/2014)... Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... its lipid franchise were highlighted in four presentations at ... Barcelona Spain . Isis has created ... effective and safe therapeutic options to treat patients with ... drug and several other drugs in clinical development designed ...
Breaking Medicine Technology:Bluegrass Vascular Technologies Names Dr. Gabriele Niederauer President And CEO 2Veracyte to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2014 2Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 2Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 3Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 4Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 5
... , the leading online Medical Transcription and Editing training ... NexGen Speech Recognition Editing and Medical Transcription Program. In ... MTEC is moving their curriculum to the next level. ... this important industry migration and is being provided to ...
... Medical Messenger , an innovative healthcare technology ... 4 is now certified to meet 2011-2012 criteria supporting ... and Reinvestment Act (ARRA) as a Complete EHR by ... record (EHR) software capable of enabling providers to meet ...
Cached Medicine Technology:MTEC Announces Release of NexGen Speech Recognition Editing and Medical Transcription Training Program 2Medical Messenger's AstralJet V4 Receives ONC-ATCB 2011/2012 Certification 2
... CONMED's family of products allows you to ... generators feature proprietary Energy Synchronous Processing Technology. ... current and voltage in all operational modes. ... to sample current and voltage over 450,000 ...
... achieves a secure clot, targeted to the ... hemostasis is needed, when control of bleeding ... and cautery, is ineffective or impractical., CROSSEAL* ... of human Biologically Active Component (BAC) and ...
GluStitch® is indicated for the closure of uncomplicated skin lacerations where there is little or no tissue loss....
... pacemaker family offers some ... automatic devices. Featuring the ... advanced technologies ever seen, ... incorporates the exclusive ventricular ...
Medicine Products: